Is Bloom Energy The Best Stock to Buy Now?
Shares of energy startup Bloom Energy (NYSE:BE) have advanced by…
Buy
54
LABU Quote, Financials, Valuation and Earnings
Last price:
$176.96
Seasonality move
:
-11.35%
Day range:
$165.50 - $179.14
52-week range:
$32.55 - $179.14
Dividend yield:
0.24%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
--
Volume:
681.7K
Avg. volume:
750.4K
1-year change:
87.73%
Market cap:
--
Revenue:
--
EPS (TTM):
--
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
LABU
Direxion Daily S&P Biotech Bull 3X Shares
|
-- | -- | -- | -- | -- |
|
DDM
ProShares Ultra Dow30
|
-- | -- | -- | -- | -- |
|
DPST
Direxion Daily Regional Banks Bull 3X Shares
|
-- | -- | -- | -- | -- |
|
UDOW
ProShares UltraPro Dow30
|
-- | -- | -- | -- | -- |
|
UYG
ProShares Ultra Financials
|
-- | -- | -- | -- | -- |
|
YINN
Direxion Daily FTSE China Bull 3X Shares
|
-- | -- | -- | -- | -- |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
LABU
Direxion Daily S&P Biotech Bull 3X Shares
|
$176.92 | -- | -- | -- | $0.10 | 0.24% | -- |
|
DDM
ProShares Ultra Dow30
|
$57.77 | -- | -- | -- | $0.15 | 0.84% | -- |
|
DPST
Direxion Daily Regional Banks Bull 3X Shares
|
$113.17 | -- | -- | -- | $0.49 | 1.58% | -- |
|
UDOW
ProShares UltraPro Dow30
|
$59.32 | -- | -- | -- | $0.23 | 1.14% | -- |
|
UYG
ProShares Ultra Financials
|
$103.49 | -- | -- | -- | $0.38 | 0.95% | -- |
|
YINN
Direxion Daily FTSE China Bull 3X Shares
|
$44.09 | -- | -- | -- | $0.26 | 1.61% | -- |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
LABU
Direxion Daily S&P Biotech Bull 3X Shares
|
-- | 3.363 | -- | -- |
|
DDM
ProShares Ultra Dow30
|
-- | 1.845 | -- | -- |
|
DPST
Direxion Daily Regional Banks Bull 3X Shares
|
-- | 3.696 | -- | -- |
|
UDOW
ProShares UltraPro Dow30
|
-- | 2.768 | -- | -- |
|
UYG
ProShares Ultra Financials
|
-- | 1.521 | -- | -- |
|
YINN
Direxion Daily FTSE China Bull 3X Shares
|
-- | 0.946 | -- | -- |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
LABU
Direxion Daily S&P Biotech Bull 3X Shares
|
-- | -- | -- | -- | -- | -- |
|
DDM
ProShares Ultra Dow30
|
-- | -- | -- | -- | -- | -- |
|
DPST
Direxion Daily Regional Banks Bull 3X Shares
|
-- | -- | -- | -- | -- | -- |
|
UDOW
ProShares UltraPro Dow30
|
-- | -- | -- | -- | -- | -- |
|
UYG
ProShares Ultra Financials
|
-- | -- | -- | -- | -- | -- |
|
YINN
Direxion Daily FTSE China Bull 3X Shares
|
-- | -- | -- | -- | -- | -- |
Direxion Daily S&P Biotech Bull 3X Shares vs. Competitors
-
Which has Higher Returns LABU or DDM?
ProShares Ultra Dow30 has a net margin of -- compared to Direxion Daily S&P Biotech Bull 3X Shares's net margin of --. Direxion Daily S&P Biotech Bull 3X Shares's return on equity of -- beat ProShares Ultra Dow30's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital LABUDirexion Daily S&P Biotech Bull 3X Shares-- -- -- DDMProShares Ultra Dow30-- -- -- -
What do Analysts Say About LABU or DDM?
Direxion Daily S&P Biotech Bull 3X Shares has a consensus price target of --, signalling downside risk potential of --. On the other hand ProShares Ultra Dow30 has an analysts' consensus of -- which suggests that it could fall by --. Given that Direxion Daily S&P Biotech Bull 3X Shares has higher upside potential than ProShares Ultra Dow30, analysts believe Direxion Daily S&P Biotech Bull 3X Shares is more attractive than ProShares Ultra Dow30.
Company Buy Ratings Hold Ratings Sell Ratings LABUDirexion Daily S&P Biotech Bull 3X Shares0 0 0 DDMProShares Ultra Dow300 0 0 -
Is LABU or DDM More Risky?
Direxion Daily S&P Biotech Bull 3X Shares has a beta of 2.522, which suggesting that the stock is 152.235% more volatile than S&P 500. In comparison ProShares Ultra Dow30 has a beta of 1.783, suggesting its more volatile than the S&P 500 by 78.335%.
-
Which is a Better Dividend Stock LABU or DDM?
Direxion Daily S&P Biotech Bull 3X Shares has a quarterly dividend of $0.10 per share corresponding to a yield of 0.24%. ProShares Ultra Dow30 offers a yield of 0.84% to investors and pays a quarterly dividend of $0.15 per share. Direxion Daily S&P Biotech Bull 3X Shares pays -- of its earnings as a dividend. ProShares Ultra Dow30 pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios LABU or DDM?
Direxion Daily S&P Biotech Bull 3X Shares quarterly revenues are --, which are smaller than ProShares Ultra Dow30 quarterly revenues of --. Direxion Daily S&P Biotech Bull 3X Shares's net income of -- is lower than ProShares Ultra Dow30's net income of --. Notably, Direxion Daily S&P Biotech Bull 3X Shares's price-to-earnings ratio is -- while ProShares Ultra Dow30's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Direxion Daily S&P Biotech Bull 3X Shares is -- versus -- for ProShares Ultra Dow30. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income LABUDirexion Daily S&P Biotech Bull 3X Shares-- -- -- -- DDMProShares Ultra Dow30-- -- -- --
-
Which has Higher Returns LABU or DPST?
Direxion Daily Regional Banks Bull 3X Shares has a net margin of -- compared to Direxion Daily S&P Biotech Bull 3X Shares's net margin of --. Direxion Daily S&P Biotech Bull 3X Shares's return on equity of -- beat Direxion Daily Regional Banks Bull 3X Shares's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital LABUDirexion Daily S&P Biotech Bull 3X Shares-- -- -- DPSTDirexion Daily Regional Banks Bull 3X Shares-- -- -- -
What do Analysts Say About LABU or DPST?
Direxion Daily S&P Biotech Bull 3X Shares has a consensus price target of --, signalling downside risk potential of --. On the other hand Direxion Daily Regional Banks Bull 3X Shares has an analysts' consensus of -- which suggests that it could fall by --. Given that Direxion Daily S&P Biotech Bull 3X Shares has higher upside potential than Direxion Daily Regional Banks Bull 3X Shares, analysts believe Direxion Daily S&P Biotech Bull 3X Shares is more attractive than Direxion Daily Regional Banks Bull 3X Shares.
Company Buy Ratings Hold Ratings Sell Ratings LABUDirexion Daily S&P Biotech Bull 3X Shares0 0 0 DPSTDirexion Daily Regional Banks Bull 3X Shares0 0 0 -
Is LABU or DPST More Risky?
Direxion Daily S&P Biotech Bull 3X Shares has a beta of 2.522, which suggesting that the stock is 152.235% more volatile than S&P 500. In comparison Direxion Daily Regional Banks Bull 3X Shares has a beta of 2.738, suggesting its more volatile than the S&P 500 by 173.842%.
-
Which is a Better Dividend Stock LABU or DPST?
Direxion Daily S&P Biotech Bull 3X Shares has a quarterly dividend of $0.10 per share corresponding to a yield of 0.24%. Direxion Daily Regional Banks Bull 3X Shares offers a yield of 1.58% to investors and pays a quarterly dividend of $0.49 per share. Direxion Daily S&P Biotech Bull 3X Shares pays -- of its earnings as a dividend. Direxion Daily Regional Banks Bull 3X Shares pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios LABU or DPST?
Direxion Daily S&P Biotech Bull 3X Shares quarterly revenues are --, which are smaller than Direxion Daily Regional Banks Bull 3X Shares quarterly revenues of --. Direxion Daily S&P Biotech Bull 3X Shares's net income of -- is lower than Direxion Daily Regional Banks Bull 3X Shares's net income of --. Notably, Direxion Daily S&P Biotech Bull 3X Shares's price-to-earnings ratio is -- while Direxion Daily Regional Banks Bull 3X Shares's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Direxion Daily S&P Biotech Bull 3X Shares is -- versus -- for Direxion Daily Regional Banks Bull 3X Shares. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income LABUDirexion Daily S&P Biotech Bull 3X Shares-- -- -- -- DPSTDirexion Daily Regional Banks Bull 3X Shares-- -- -- --
-
Which has Higher Returns LABU or UDOW?
ProShares UltraPro Dow30 has a net margin of -- compared to Direxion Daily S&P Biotech Bull 3X Shares's net margin of --. Direxion Daily S&P Biotech Bull 3X Shares's return on equity of -- beat ProShares UltraPro Dow30's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital LABUDirexion Daily S&P Biotech Bull 3X Shares-- -- -- UDOWProShares UltraPro Dow30-- -- -- -
What do Analysts Say About LABU or UDOW?
Direxion Daily S&P Biotech Bull 3X Shares has a consensus price target of --, signalling downside risk potential of --. On the other hand ProShares UltraPro Dow30 has an analysts' consensus of -- which suggests that it could fall by --. Given that Direxion Daily S&P Biotech Bull 3X Shares has higher upside potential than ProShares UltraPro Dow30, analysts believe Direxion Daily S&P Biotech Bull 3X Shares is more attractive than ProShares UltraPro Dow30.
Company Buy Ratings Hold Ratings Sell Ratings LABUDirexion Daily S&P Biotech Bull 3X Shares0 0 0 UDOWProShares UltraPro Dow300 0 0 -
Is LABU or UDOW More Risky?
Direxion Daily S&P Biotech Bull 3X Shares has a beta of 2.522, which suggesting that the stock is 152.235% more volatile than S&P 500. In comparison ProShares UltraPro Dow30 has a beta of 2.681, suggesting its more volatile than the S&P 500 by 168.05%.
-
Which is a Better Dividend Stock LABU or UDOW?
Direxion Daily S&P Biotech Bull 3X Shares has a quarterly dividend of $0.10 per share corresponding to a yield of 0.24%. ProShares UltraPro Dow30 offers a yield of 1.14% to investors and pays a quarterly dividend of $0.23 per share. Direxion Daily S&P Biotech Bull 3X Shares pays -- of its earnings as a dividend. ProShares UltraPro Dow30 pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios LABU or UDOW?
Direxion Daily S&P Biotech Bull 3X Shares quarterly revenues are --, which are smaller than ProShares UltraPro Dow30 quarterly revenues of --. Direxion Daily S&P Biotech Bull 3X Shares's net income of -- is lower than ProShares UltraPro Dow30's net income of --. Notably, Direxion Daily S&P Biotech Bull 3X Shares's price-to-earnings ratio is -- while ProShares UltraPro Dow30's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Direxion Daily S&P Biotech Bull 3X Shares is -- versus -- for ProShares UltraPro Dow30. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income LABUDirexion Daily S&P Biotech Bull 3X Shares-- -- -- -- UDOWProShares UltraPro Dow30-- -- -- --
-
Which has Higher Returns LABU or UYG?
ProShares Ultra Financials has a net margin of -- compared to Direxion Daily S&P Biotech Bull 3X Shares's net margin of --. Direxion Daily S&P Biotech Bull 3X Shares's return on equity of -- beat ProShares Ultra Financials's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital LABUDirexion Daily S&P Biotech Bull 3X Shares-- -- -- UYGProShares Ultra Financials-- -- -- -
What do Analysts Say About LABU or UYG?
Direxion Daily S&P Biotech Bull 3X Shares has a consensus price target of --, signalling downside risk potential of --. On the other hand ProShares Ultra Financials has an analysts' consensus of -- which suggests that it could fall by --. Given that Direxion Daily S&P Biotech Bull 3X Shares has higher upside potential than ProShares Ultra Financials, analysts believe Direxion Daily S&P Biotech Bull 3X Shares is more attractive than ProShares Ultra Financials.
Company Buy Ratings Hold Ratings Sell Ratings LABUDirexion Daily S&P Biotech Bull 3X Shares0 0 0 UYGProShares Ultra Financials0 0 0 -
Is LABU or UYG More Risky?
Direxion Daily S&P Biotech Bull 3X Shares has a beta of 2.522, which suggesting that the stock is 152.235% more volatile than S&P 500. In comparison ProShares Ultra Financials has a beta of 1.958, suggesting its more volatile than the S&P 500 by 95.781%.
-
Which is a Better Dividend Stock LABU or UYG?
Direxion Daily S&P Biotech Bull 3X Shares has a quarterly dividend of $0.10 per share corresponding to a yield of 0.24%. ProShares Ultra Financials offers a yield of 0.95% to investors and pays a quarterly dividend of $0.38 per share. Direxion Daily S&P Biotech Bull 3X Shares pays -- of its earnings as a dividend. ProShares Ultra Financials pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios LABU or UYG?
Direxion Daily S&P Biotech Bull 3X Shares quarterly revenues are --, which are smaller than ProShares Ultra Financials quarterly revenues of --. Direxion Daily S&P Biotech Bull 3X Shares's net income of -- is lower than ProShares Ultra Financials's net income of --. Notably, Direxion Daily S&P Biotech Bull 3X Shares's price-to-earnings ratio is -- while ProShares Ultra Financials's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Direxion Daily S&P Biotech Bull 3X Shares is -- versus -- for ProShares Ultra Financials. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income LABUDirexion Daily S&P Biotech Bull 3X Shares-- -- -- -- UYGProShares Ultra Financials-- -- -- --
-
Which has Higher Returns LABU or YINN?
Direxion Daily FTSE China Bull 3X Shares has a net margin of -- compared to Direxion Daily S&P Biotech Bull 3X Shares's net margin of --. Direxion Daily S&P Biotech Bull 3X Shares's return on equity of -- beat Direxion Daily FTSE China Bull 3X Shares's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital LABUDirexion Daily S&P Biotech Bull 3X Shares-- -- -- YINNDirexion Daily FTSE China Bull 3X Shares-- -- -- -
What do Analysts Say About LABU or YINN?
Direxion Daily S&P Biotech Bull 3X Shares has a consensus price target of --, signalling downside risk potential of --. On the other hand Direxion Daily FTSE China Bull 3X Shares has an analysts' consensus of -- which suggests that it could fall by --. Given that Direxion Daily S&P Biotech Bull 3X Shares has higher upside potential than Direxion Daily FTSE China Bull 3X Shares, analysts believe Direxion Daily S&P Biotech Bull 3X Shares is more attractive than Direxion Daily FTSE China Bull 3X Shares.
Company Buy Ratings Hold Ratings Sell Ratings LABUDirexion Daily S&P Biotech Bull 3X Shares0 0 0 YINNDirexion Daily FTSE China Bull 3X Shares0 0 0 -
Is LABU or YINN More Risky?
Direxion Daily S&P Biotech Bull 3X Shares has a beta of 2.522, which suggesting that the stock is 152.235% more volatile than S&P 500. In comparison Direxion Daily FTSE China Bull 3X Shares has a beta of 0.897, suggesting its less volatile than the S&P 500 by 10.334%.
-
Which is a Better Dividend Stock LABU or YINN?
Direxion Daily S&P Biotech Bull 3X Shares has a quarterly dividend of $0.10 per share corresponding to a yield of 0.24%. Direxion Daily FTSE China Bull 3X Shares offers a yield of 1.61% to investors and pays a quarterly dividend of $0.26 per share. Direxion Daily S&P Biotech Bull 3X Shares pays -- of its earnings as a dividend. Direxion Daily FTSE China Bull 3X Shares pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios LABU or YINN?
Direxion Daily S&P Biotech Bull 3X Shares quarterly revenues are --, which are smaller than Direxion Daily FTSE China Bull 3X Shares quarterly revenues of --. Direxion Daily S&P Biotech Bull 3X Shares's net income of -- is lower than Direxion Daily FTSE China Bull 3X Shares's net income of --. Notably, Direxion Daily S&P Biotech Bull 3X Shares's price-to-earnings ratio is -- while Direxion Daily FTSE China Bull 3X Shares's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Direxion Daily S&P Biotech Bull 3X Shares is -- versus -- for Direxion Daily FTSE China Bull 3X Shares. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income LABUDirexion Daily S&P Biotech Bull 3X Shares-- -- -- -- YINNDirexion Daily FTSE China Bull 3X Shares-- -- -- --
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Berkshire Hathaway Stock Undervalued?
Berkshire Hathaway (NYSE:BRK.A,BRK.B) has undershot the market this year, returning…
Is Oracle Stock Undervalued?
Shares of Oracle (NYSE:ORCL) rocketed higher earlier this year when…
Stock Ideas
Buy
55
Is NVDA Stock a Buy?
Market Cap: $4.5T
P/E Ratio: 63x
Buy
53
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 36x
Buy
59
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
60
AAOI alert for Dec 23
Applied Optoelectronics, Inc. [AAOI] is up 3.72% over the past day.
Buy
52
ABVX alert for Dec 23
Abivax SA [ABVX] is up 0.33% over the past day.
Buy
69
QBTS alert for Dec 23
D-Wave Quantum, Inc. [QBTS] is down 5.81% over the past day.
